5 hours ago The PSA Doubling Time Calculator calculates rate of PSA doubling in prostate cancer (correlates with survival). ... Forgot Password? Email Address. ... Charles R. Pound, MD, is the chief of urology in the department of surgery at the University of Mississippi Medical Center in …
Show more
See More
7 hours ago This is a list of all Urology related medical scores and algorithms with their corresponding calculator/app. ... Forgot your password? Not a Member yet? Please Sign Up! Email. ... PSA Density Calculator for Prostate Tumor Volume and Density.
Show more
See More
9 hours ago forgot password? Password reset. Share. Grand Rounds in Urology. added: a year ago. views: 844. ... discusses the development of Kaiser Permanente’s new prostate cancer risk calculator and its merits. Dr. ... PSA, body-mass index, family history, number of prior negative biopsies, digital rectal exam (DRE), and prostate volume. They created 3 ...
Show more
See More
8 hours ago PSA rise of ≥2 ng/mL above the nadir PSA level – following radiation therapy. PSADT is used as an indicator of biochemical and clinical progression. However, please note that since prostate specific antigen elevations may accompany different conditions, including benign prostatic hyperplasia (BPH) , PSA doubling time has a limited value in ...
Show more
See More
4 hours ago PSA density helps distinguish between Benign prostatic hyperplasia (BPH) and prostate cancer. The density cut-off of 0.15-0.20 ng/mL/cc is used to help guide clinical decision between a watch-and-wait or an invasive approach when managing prostate carcinoma. Prostate Volume in cc = L x W x H x π/6. Prostate Density in ng/mL/cc = PSA / Volume.
Show more
See More
1 hours ago Jul 23, 2012 . The 4-yr future risk calculator—an individualized multivariate model including age, prostate-specific antigen, digital rectal examination, family history, prostate volume, and previous biopsy status—may be a promising tool in reducing uncertainty, unnecessary testing, and overdiagnosis with regard to prostate cancer.
Show more
See More
7 hours ago May 17, 2018 . Both trials were performed during the 1990s and hence based on the study populations and clinical practice standards of that time. The PCPT was a heavily screened population of primarily healthy North American white men, requiring a PSA ≤3 ng/ml and a normal DRE to enter the trial, annual PSA and DRE screening, and a required end-of-study biopsy at …
Show more
See More
7 hours ago May 12, 2018 . Serum prostate-specific antigen (PSA) and total PV were measured in each subject. Potential sociodemographic and clinical variables including age, weight, comorbidities and International Prostate Symptom Score (IPSS) were collected. Of 1,034 subjects, 837 were used in building the PV calculator using regression analysis.
Show more
See More
11 hours ago Select Forgot your username/password? on the Login page. Select Use phone number to reset password. Select your country prefix. Enter your phone number in the Phone Number box and press the Submit button. Select verify and complete the process. This will send a 6-digit number to your phone. Enter the number in the Enter Code (6-digit) box and ...
Show more
See More
2 hours ago Enter your username. The one that you use to sign in with. na. Brazil EU Nordic & East EU West Japan Korea Latin America North Latin America South North America Oceania Public Beta Russia Turkey. Username. Username. Forgot Username?
Show more
See More
4 hours ago Dec 25, 2001 . Objective. To investigate the clinical significance of the free-to-total prostate-specific antigen (PSA) ratio in improving the specificity of PSA measurement for detecting prostate cancer within the diagnostic intermediate range (4–10 ng/mL total PSA) in patients referred for the treatment of urinary symptoms.
Show more
See More
4 hours ago Dec 03, 2019 . PSA: Prostate Specific Antigen, DRE: Digital Rectal Exam, PV: Prostate Volume measured by DRE, ISUP: International Society of Urological Pathology. The ERSPC-Cribriform-RC is a practical and easy-to-use risk calculator (Figure 2). The urologist only has to know the patient’s age, PSA result and findings of the digital rectal examination (DRE).
Show more
See More
10 hours ago The Rotterdam Prostate Cancer Risk Calculator (RPCRC) is a well-validated tool for upfront risk stratification to reduce the number of prostate biopsies and magnetic resonance imaging scans among both biopsy-naïve and previously biopsied men. The presence of invasive cribriform and/or intraductal carcinoma (CR/IDC) identifies men with aggressive grade group …
Show more
See More
1 hours ago Oct 08, 2010 . If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. ... Prostate Cancer Detection in the “Grey Area” of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun’s Nomogram, Two Risk Estimators Incorporating Prostate ...
Show more
See More
5 hours ago Dec 27, 2006 . The many methods used to calculate PSA velocity using the same PSA data can produce markedly different results, which may alter the decision to proceed to prostate biopsy. Linear regression should be the method of choice for calculating PSA velocity.
Show more
See More
3 hours ago Dec 01, 2014 . Both prostate cancer antigen 3 and a kallikrein panel have some added value to the European Randomised study of Screening for Prostate Cancer digital rectal examination–based risk calculator for detecting prostate cancer in prescreened men. Further research should focus on men with a previous negative biopsy, for whom markers may …
Show more
See More
5 hours ago Aug 17, 2007 . A new predictor of survival, delta-time PSA interval (ΔT) was described. RESULTS. PSA HL categories were strongly related with WG criteria (P = 0.0001). PSA HL TTF differed among PSA HL categories: 4.2, 2.3, and 0.9 months for R, LP, and IP patients, respectively, and their respective median OS were 27, 19.7, and 12.3 months (PP = 0.0001 ...
Show more
See More
5 hours ago If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. ... Department of Urology, Erasmus University Medical Center, P.O. Box 2040, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. ... prostate-specific antigen [PSA], presence of abnormal digital rectal examination ...
Show more
See More
3 hours ago To investigate the diagnostic significance of prostate-specific antigen (PSA), density (PSAD), and PSAD adjusted by transition zone volume (PSATZD) in men …
Show more
See More
PSAD is used as prognostication tool in the prostate cancer diagnosis protocol and is obtained by dividing the serum prostate-specific antigen (PSA) by the volume of the prostate obtained following ultrasound measurement. Prostate Volume in cc = L x W x H x π/6 Prostate Density in ng/mL/cc = PSA / Volume
PSA doubling time = ln (2) / PSA Slope PSA Slope = (ln (PSA level 2) – ln (PSA level 1)) / Time (no. of months) Velocity = (PSA level 2 – PSA level 1) / Time (no. of months) Where: Time (no. of months) = Second Test Date - First Test Date Jump to: 1. PSA Doubling Time Calculator 2. PSA Doubling Time Explained 3. References First Test Date
For patients with biochemical recurrence of prostate cancer, optimal PSADT calculation should include all PSA values of the individual within two years of initially documented PSA recurrence. Entering more values improves accuracy of estimation.
From a population-based database of PSA results, men with initial PSA < 10.0 ng/ml and a subsequent diagnosis of prostate cancer or benign histology were identified. Those with ≥3 PSA tests before diagnosis carried out over a minimum of 18 mo were included.